U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07537634) titled 'Vonoprazan-based Versus Esomeprazole-based Triple Therapy for Helicobacter Pylori Eradication' on April 09.
Brief Summary: The goal of this clinical trial is to compare the efficacy and safety of vonoprazan-based levofloxacin-containing triple therapy with esomeprazole-based levofloxacin-containing triple therapy for eradication of Helicobacter pylori infection in adults with dyspepsia.
The main questions it aims to answer are whether vonoprazan-based triple therapy achieves a higher eradication rate of H. pylori, whether it provides greater improvement in dyspeptic symptoms, and what adverse effects are associated with each regim...